Simpler Grants.gov #PA-25-304

NIH R21 Grant for Early-Stage Biomedical and Clinical Research (No Clinical Trials)

The National Institutes of Health (NIH) is inviting applications for the Exploratory/Developmental Research Project Grant (Parent R21), focused on supporting innovative, early-stage research in biomedical, behavioral, or clinical fields. - Government Buyer: - National Institutes of Health (NIH) is the sole government agency involved - Products/Services Requested: - Funding for exploratory and developmental research projects (R21 grants) - No specific products, part numbers, or purchase quantities are listed - Projects must be early-stage, high-risk, and aim to develop novel techniques, agents, methodologies, models, or applications - Clinical trials are not permitted under this opportunity - Notable Requirements: - Eligible applicants include nonprofits, government entities, educational institutions, and businesses - No cost sharing or matching is required - Research areas span a wide range, including but not limited to: alcohol research, blood diseases, communication disorders, lung diseases, environmental health, heart and lung diseases, aging, medical library assistance, cardiovascular diseases, allergy and infectious diseases, complementary and integrative health, vision, oral diseases, mental health, drug addiction, technological innovations for human health, nursing, hazardous substances, child health, human genome, sleep disorders, minority health, arthritis, cancer biology, cancer detection, cancer control, cancer cause and prevention, and cancer treatment - OEMs and Vendors: - No specific OEMs or vendors are mentioned, as this is a grant for research projects, not a procurement of goods or commercial services

Description

The NIH Exploratory/Developmental Grant supports exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research. Eligible applicants include nonprofit organizations, government entities, educational institutions, businesses, and other specified groups. The grant is funded by the National Institutes of Health and does not require cost sharing or matching.

View original listing